Curewell Pharmakon Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
- Paid Up Capital ₹ 0.60 M
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.37 M
- Revenue Growth -42.64%
- Profit Growth 11.51%
- Ebitda -119.64%
- Net Worth 4.01%
- Total Assets -23.65%
About Curewell Pharmakon
Curewell Pharmakon Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 March 1989 and has a history of 35 years and ten months. Its registered office is in Jammu And Kashmir, Jammu & Kashmir.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹4.37 M.
Anu Gupta and Sumati Mahajan serve as directors at the Company.
Company Details
-
LocationJammu And Kashmir, Jammu & Kashmir
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231JK1989PTC001099
-
Company No.
001099
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Mar 1989
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at Curewell Pharmakon?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumati Mahajan
|
Director | 31-Dec-2020 | Current |
|
Anu Gupta
|
Director | 17-Nov-2017 | Current |
Financial Performance of Curewell Pharmakon.
Curewell Pharmakon Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 42.64% decrease. The company also saw a substantial improvement in profitability, with a 11.51% increase in profit. The company's net worth moved up by a moderate rise of 4.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curewell Pharmakon?
In 2017, Curewell Pharmakon had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.37 M
₹0
Charges Breakdown by Lending Institutions
- Central Bank Of India : 0.28 Cr
- The Jammu And Kashmir Bank Limited : 0.11 Cr
- Hdfc Bank Limited : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2023 | Hdfc Bank Limited | ₹0.52 M | Open |
| 29 May 2023 | The Jammu And Kashmir Bank Limited | ₹1.05 M | Open |
| 24 Dec 2002 | Central Bank Of India | ₹2.20 M | Open |
| 28 Jan 1993 | Central Bank Of India | ₹0.20 M | Open |
| 21 Jul 1992 | Central Bank Of India | ₹0.40 M | Open |
How Many Employees Work at Curewell Pharmakon?
Curewell Pharmakon has a workforce of 2 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curewell Pharmakon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curewell Pharmakon's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
